Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) was upgraded by analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a report released on Saturday.
RKTO has been the subject of several other research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket One Inc. Common Stock in a research note on Friday, April 24th. D. Boral Capital reissued a “buy” rating and issued a $5.00 price objective on shares of Rocket One Inc. Common Stock in a research note on Wednesday, March 25th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Rocket One Inc. Common Stock has a consensus rating of “Hold” and a consensus price target of $5.00.
Check Out Our Latest Report on Rocket One Inc. Common Stock
Rocket One Inc. Common Stock Stock Performance
Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.03).
Hedge Funds Weigh In On Rocket One Inc. Common Stock
Several institutional investors and hedge funds have recently bought and sold shares of the company. Lido Advisors LLC grew its holdings in Rocket One Inc. Common Stock by 100.0% in the first quarter. Lido Advisors LLC now owns 39,000 shares of the company’s stock worth $33,000 after purchasing an additional 19,500 shares during the last quarter. DRW Securities LLC acquired a new position in Rocket One Inc. Common Stock during the fourth quarter valued at $257,000. Geode Capital Management LLC lifted its position in Rocket One Inc. Common Stock by 18.0% during the fourth quarter. Geode Capital Management LLC now owns 181,112 shares of the company’s stock valued at $179,000 after purchasing an additional 27,577 shares during the period. Kestra Private Wealth Services LLC acquired a new position in Rocket One Inc. Common Stock during the third quarter valued at $51,000. Finally, Citadel Advisors LLC acquired a new position in Rocket One Inc. Common Stock during the third quarter valued at $232,000. 7.08% of the stock is owned by hedge funds and other institutional investors.
About Rocket One Inc. Common Stock
Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.
Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.
See Also
- Five stocks we like better than Rocket One Inc. Common Stock
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Rocket One Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket One Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
